Related Experiment Video
Updated: May 13, 2026

Rapid In Situ Hybridization using Oligonucleotide Probes on Paraformaldehyde-prefixed Brain of Rats with Serotonin Syndrome
Published on: September 23, 2015
Polymorphisms of the 5-hydroxytryptamine 2A/2C receptor genes and 5-hydroxytryptamine transporter gene in Chinese
Hongbin Chen1, Ke Hu, Jianyong Zhu
1Division of Respiratory Disease, Renmin Hospital of Wuhan University, 99 Zhangzhidong Road, Wuchang, Wuhan, 430060, China.
Background:
It is known that there is a genetic predisposition to OSAHS. Polymorphisms of the 5-hydroxytryptamine (5-HT) 2A/2C receptors (5-HTR 2A/2C) genes and 5-HT transporter (5-HTT) gene may be associated with the pathogenesis of obstructive sleep apnea-hypopnea syndrome (OSAHS).
Objectives:
In this study, we aimed to investigate the prevalence of polymorphisms of the 5-HTR 2A/2C genes and the 5-HTT gene in the Chinese Han OSAHS population.
Methods:
A total of 226 unrelated subjects of the Chinese Han population, including 121 OSAHS patients and 105 healthy controls, were involved in the study. The A1438G and T102C polymorphisms of the 5-HTR 2A gene, G796C polymorphisms of the 5-HTR 2C gene, and two polymorphisms (gene-linked polymorphic region [LPR] and variable number tandem repeat [VNTR]) of the 5-HTT gene were identified by polymerase chain reaction (PCR)-RFLP.
Results:
Compared with the control group, the OSAHS group had significantly higher AA genotype and A allele frequencies in the A1438G polymorphisms of the 5-HTR 2A gene, and had significantly higher frequencies of 10/10, 12/10 genotypes and the allele 10 of 5-HTT-VNTR. There were no significant differences between the genotype distribution and allele frequencies of the OSAHS group and the control group regarding the T102C polymorphisms of the 5-HTR 2A gene and the G796C polymorphisms of the 5-HTR 2C gene, the frequencies of the S or L allele and the S/S, S/L or L/L genotypes in 5-HTT-LPR.
Conclusions:
The A1438G polymorphism of the 5-HTR 2A gene might be involved in the pathogenesis in OSAHS subjects of the Chinese Han population. Meanwhile, our findings support the argument that 5-HTT polymorphism appears to be associated with susceptibility to OSAHS, because the allele 10 of 5-HTT-VNTR might be a susceptible factor.
Insights
Genetic variations in serotonin receptors and transporters are linked to obstructive sleep apnea-hypopnea syndrome (OSAHS). The 5-HTR 2A gene A1438G polymorphism and 5-HTT-VNTR allele 10 may increase OSAHS susceptibility in the Chinese Han population.
Area of Science:
- Genetics
- Sleep Medicine
- Pharmacogenomics
Background:
- Obstructive sleep apnea-hypopnea syndrome (OSAHS) has a known genetic predisposition.
- Polymorphisms in serotonin receptor genes (5-HTR 2A/2C) and the serotonin transporter gene (5-HTT) are potential contributors to OSAHS pathogenesis.
Purpose of the Study:
- To investigate the prevalence of specific gene polymorphisms in the Chinese Han population with OSAHS.
- To explore the association between 5-HTR 2A/2C and 5-HTT gene polymorphisms and OSAHS susceptibility.
Main Methods:
- Genotyping of 226 Chinese Han individuals (121 OSAHS patients, 105 controls) using PCR-RFLP.
- Analysis of A1438G and T102C polymorphisms in 5-HTR 2A, G796C in 5-HTR 2C, and LPR/VNTR polymorphisms in 5-HTT.
Main Results:
- Significantly higher AA genotype and A allele frequencies of 5-HTR 2A A1438G polymorphism in OSAHS patients compared to controls.
- Increased frequencies of 10/10, 12/10 genotypes and the 10 allele for 5-HTT-VNTR in the OSAHS group.
- No significant differences for 5-HTR 2A T102C, 5-HTR 2C G796C, and 5-HTT-LPR polymorphisms between groups.
Conclusions:
- The A1438G polymorphism of the 5-HTR 2A gene may play a role in OSAHS pathogenesis in the Chinese Han population.
- 5-HTT VNTR polymorphism, specifically allele 10, appears to be associated with increased susceptibility to OSAHS.
Related Concept Videos
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Single Nucleotide Polymorphisms-SNPs
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...